²é¿´: 1281  |  »Ø¸´: 7
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

rb

ľ³æ (ÖøÃûдÊÖ)

С±¿³æ³æ

[½»Á÷] ¡¾×ªÔØ¡¿·ÖÏí¡¶×ªÈ¾¼¼ÊõÒªµã¼°×ªÈ¾ÊÔ¼ÁµÄÑ¡Ôñ¡·¡¾ÒÑËÑÎÞÖØ¸´¡¿

[watermark]תȾ¼¼ÊõÒªµã¼°×ªÈ¾ÊÔ¼ÁµÄÑ¡Ôñ

תȾ¼¼ÊõÊÇÖ¸½«ÍâÔ´·Ö×ÓÈçDNA£¬RNAµÈµ¼ÈëÕæºËϸ°ûµÄ¼¼Êõ£¬ËüÊÇÑо¿»ùÒò±í´ïµ÷¿Ø£¬Í»±ä·ÖÎöµÈµÄ³£¹æ¹¤¾ß¡£Ëæ×ʦÄÜÑо¿µÄÐËÆð£¬ÆäÓ¦ÓÃÔ½À´Ô½¹ã·º¡£ÒÔϾÍÏò´ó¼Ò½éÉÜһЩתȾµÄ¼¼ÊõÒªµã¼°ÊÐÃæÉÏÖ÷ÒªµÄתȾÊÔ¼ÁÀàÐ͵ÄÑ¡Ôñ¡£



³£¹æ×ªÈ¾¼¼Êõ¿É·ÖΪÁ½´óÀ࣬һÀàÊÇ˲ʱתȾ£¬Ò»ÀàÊÇÎȶ¨×ªÈ¾£¨ÓÀ¾ÃתȾ£©¡£Ç°ÕßÍâÔ´DNA/RNA²»ÕûºÏµ½ËÞÖ÷ȾɫÌåÖУ¬Òò´ËÒ»¸öËÞÖ÷ϸ°ûÖпɴæÔÚ¶à¸ö¿½±´Êý£¬²úÉú¸ßˮƽµÄ±í´ï£¬µ«Í¨³£Ö»³ÖÐø¼¸Ì죬¶àÓÃÓÚÆô¶¯×ÓºÍÆäËüµ÷¿ØÔª¼þµÄ·ÖÎö¡£Ò»°ãÀ´Ëµ£¬³¬ÂÝÐýÖÊÁ£DNAתȾЧÂʽϸߣ¬ÔÚתȾºó24-96СʱÄÚ£¨ÒÀÀµÓÚ¸÷ÖÖ²»Í¬µÄ¹¹½¨£©·ÖÎö½á¹û£¬³£³£Óõ½Ò»Ð©±¨¸æÏµÍ³ÈçÓ«¹âµ°°×£¬¦Â°ëÈéÌÇÜÕøµÈÀ´°ïÖú¼ì²â¡£ºóÕßÒ²³ÆÎȶ¨×ªÈ¾£¬ÍâÔ´DNA¼È¿ÉÒÔÕûºÏµ½ËÞÖ÷ȾɫÌåÖУ¬Ò²¿ÉÄÜ×÷ΪһÖÖÓÎÀëÌ壨episome£©´æÔÚ¡£¾¡¹ÜÏßÐÔDNA±È³¬ÂÝÐýDNAתÈëÁ¿µÍµ«ÕûºÏÂʸߡ£ÍâÔ´DNAÕûºÏµ½È¾É«ÌåÖиÅÂʺÜС£¬´óÔ¼1/104תȾϸ°ûÄÜÕûºÏ£¬Í¨³£ÐèҪͨ¹ýһЩѡÔñÐÔ±ê¼Ç£¬ÈçÀ´°±±û»ù×ªÒÆÃ¸£¨APH£»ÐÂÃ¹ËØ¿¹ÐÔ»ùÒò£©£¬³±Ã¹ËØBÁ×Ëá×ªÒÆÃ¸£¨HPH£©£¬ÐØÜÕ¼¤Ã¸£¨TK£©µÈ·´¸´É¸Ñ¡£¬µÃµ½Îȶ¨×ªÈ¾µÄͬԴϸ°ûϵ¡£



תȾЧÂÊÊÕ¶àÖÖÒòËØÓ°Ï죬Ö÷ÒªÒòËØÓÐÏÂÃæ¼¸¸ö£º

1. ϸ°ûÅàÑøÎï

½¡¿µµÄϸ°ûÅàÑøÎïÊdzɹ¦×ªÈ¾µÄ»ù´¡¡£²»Í¬Ï¸°ûÓв»Í¬µÄÅàÑø»ù£¬ÑªÇåºÍÌí¼ÓÎï¡£µÍµÄϸ°û´úÊý£¨<50£©ÄÜÈ·±£»ùÒòÐͲ»±ä¡£¸ßµÄתȾЧÂÊÐèÒªÒ»¶¨µÄϸ°ûÃܶȣ¬Ò»°ãµÄתȾÊÔ¼Á¶¼»áÓÐרÃŵÄ˵Ã÷¡£ÍƼöÔÚתȾǰ24Сʱ·Öϸ°û£¬Õ⽫ÌṩÕý³£Ï¸°û´úл£¬Ôö¼Ó¶ÔÍâÔ´DNAÉãÈëµÄ¿ÉÄÜ¡£Ò»¶¨Òª±ÜÃâϸ¾ú£¬Ö§Ô­Ìå»òÕæ¾úµÄÎÛȾ¡£



2. ѪÇå

´ó¶àÊýÅàÑø»ùÔÚʹÓÃǰÐèÒª¼ÓѪÇ塣̥ţѪÇ壨FCS£©¾­³£Óõ½£¬±ãÒËÒ»µãµÄÓÐÂí»òţѪÇ塣ͨ³£µÄ£¬ÑªÇåÊÇÒ»ÖÖ°üº¬Éú³¤Òò×Ó¼°ÆäËü¸¨ÖúÒò×ӵIJ»È·ÇгɷֵÄÌí¼ÓÎ¶Ô²»Í¬Ï¸°ûµÄÉú³¤×÷ÓÃÓкܴóµÄ²î±ð¡£ÑªÇåÖÊÁ¿µÄ±ä»¯Ö±½ÓÓ°ÏìתȾЧÂÊ¡£Òò´ËÔÚתȾǰ½¨ÒéÏȲâ(תÓÒ)

ÊÔ³ö¶Ôϸ°ûÉú³¤Á¼ºÃµÄѪÇåÅúºÅ£¬×ªÈ¾Ê±ÓÃͬһÅúºÅµÄѪÇ壬²¢Í¬Ê±×ö¸º¶ÔÕÕ£¨²»¼ÓתȾÊÔ¼Á¼°ÍâÔ´DNA£©ÒÔ²âÊÔϸ°ûÉú³¤ÊÇ·ñÕý³£¡£ÓÐЩתȾ¼¼ÊõÈçÖ¬ÖÊÌåתȾÔÚÓÐѪÇå´æÔÚÇé¿öÏÂЧÂʺܵͣ¬Òò´ËÔÚתȾǰҪ³ýѪÇå¡£µ«ÓÐЩ¶Ô´ËÃô¸ÐµÄϸ°ûÈçÔ­´úϸ°û»áÊܵ½ËðÉË£¬ÉõÖÁËÀÍöµ¼ÖÂתȾЧÂʼ«µÍ¡£



3. ÔØÌå¹¹½¨

×ªÈ¾ÔØÌåµÄ¹¹½¨£¨²¡¶¾ÔØÌ壬ÖÊÁ£DNA£¬RNA£¬PCR²úÎ¹ÑºËÜÕËáµÈ£©Ò²Ó°ÏìתȾ½á¹û¡£²¡¶¾ÔØÌå¶ÔÌØ¶¨ËÞÖ÷ϸ°û¸ÐȾЧÂʽϸߣ¬µ«²»Í¬²¡¶¾ÔØÌåÓÐÆäÌØ¶¨µÄËÞÖ÷£¬ÓеĻ¹ÒªÇóÌØ¶¨µÄϸ°ûÖÜÆÚ£¬ÈçÄæ×ªÂ¼²¡¶¾ÐèÇÖȾ·ÖÁÑÆÚµÄËÞÖ÷ϸ°û£¬´ËÍ⻹Ð迼ÂÇһЩ°²È«ÎÊÌ⣨Èç»ùÒòÎÛȾ£©¡£³ýÔØÌå¹¹½¨Íâ£¬ÔØÌåµÄÐÎ̬¼°´óС¶ÔתȾЧÂÊÒ²Óв»Í¬µÄÓ°Ï죬ÈçÇ°ÃæÌáµ½µÄ³¬ÂÝÐý¼°ÏßÐÔDNA¶Ô˲ʱºÍÎȶ¨×ªÈ¾µÄÓ°Ïì¡£Èç¹û»ùÒò²úÎï¶Ôϸ°ûÓж¾ÐÔ×÷Óã¬×ªÈ¾Ò²ºÜÄѽøÐУ¬Òò´ËÑ¡Ôñ×é³É»ò¿Éµ÷¿Ø£¬Ç¿¶ÈºÏÊÊµÄÆô¶¯×ÓÒ²ºÜÖØÒª£¬Í¬Ê±×ö¿ÕÔØÌå¼°ÆäËü»ùÒòµÄÏàÍ¬ÔØÌå¹¹½¨µÄתȾÕý¶ÔÕÕ¿ÉÅųý¶¾ÐÔÓ°ÏìµÄ¸ÉÈÅ¡£



4. DNAÖÊÁ¿

DNAÖÊÁ¿¶ÔתȾЧÂÊÓ°Ïì·Ç³£´ó¡£Ò»°ãµÄתȾ¼¼Êõ£¨ÈçÖ¬ÖÊÌåµÈ£©»ùÓÚµçºÉÎüÒýÔ­Àí£¬Èç¹ûDNA²»´¿£¬Èç´øÉÙÁ¿µÄÑÎÀë×Ó£¬µ°°×£¬´úлÎïÎÛȾ¶¼»áÏÔÖøÓ°ÏìתȾ¸´ºÏÎïµÄÓÐЧÐγɼ°×ªÈ¾µÄ½øÐС£ºËËá´¿»¯ÊÀ½çµÚÒ»Æ·ÅÆµÂ¹úQIAGEN¹«Ë¾ÌṩµÄ³¬´¿ÖÊÁ£³éÌáÊÔ¼ÁºÐ£¬ÄÜ´ïµ½Á½±¶2x CsClÌݶÈÀëÐÄÒÔÉϵĴ¿¶ÈЧ¹û£¬Ê¹Äú²»±ØÎªDNAÖÊÁ¿²ÙÐÄ¡£´ËÍ⣬¶ÔһЩÄÚ¶¾ËØÃô¸ÐµÄϸ°û£¨ÈçÔ­´úϸ°û£¬Ðü¸¡Ï¸°ûºÍÔìѪϸ°û£©£¬QIAGEN»¹Ìṩ¿ÉÈ¥³ýÄÚ¶¾ËØÎÛȾµÄÖÊÁ£³éÌáÊÔ¼ÁºÐ£¬ÔÚÖÊÁ£³éÌá¹ý³ÌÖÐÓÐЧȥ³ýÖ¬¶àÌÇ·Ö×Ó£¬±£Ö¤ÀíÏëµÄתȾЧ¹û¡£



5.תȾ¼¼Êõ

תȾ¼¼ÊõµÄÑ¡Ôñ¶ÔתȾ½á¹ûÓ°ÏìÒ²ºÜ´ó£¬Ðí¶àתȾ·½·¨ÐèÒªÓÅ»¯DNAÓëתȾÊÔ¼Á±ÈÀý£¬Ï¸°ûÊýÁ¿£¬ÅàÑø¼°¼ì²âʱ¼äµÈ¡£Ò»Ð©´«Í³µÄתȾ¼¼Êõ£¬ÈçDEAEÓÒÐýÌÇÜÕ·¨£¬Á×Ëá¸Æ·¨£¬µç´©¿×·¨£¬Ö¬ÖÊÌå·¨¸÷ÓÐÀû±×£¬ÆäÖ÷ÒªÔ­Àí¼°Ó¦ÓÃÌØµã¼ûÏ£º





תȾ·½·¨ Ô­Àí Ó¦ÓÃ ÌØµã

DEAE-ÓÒÐýÌÇÜÕ·¨ ´øÕýµçµÄDEAE-ÓÒÐýÌÇÜÕÓëºËËá´ø¸ºµçµÄÁ×Ëá¹Ç¼ÜÏ໥×÷ÓÃÐγɵĸ´ºÏÎﱻϸ°ûÄÚÍÌ Ë²Ê±ÐÔתȾ Ïà¶Ô¼ò±ã¡¢½á¹û¿ÉÖØ¸´

µ«¶Ôϸ°ûÓÐÒ»¶¨µÄ¶¾¸±×÷ÓÃ

תȾʱÐè³ýѪÇå



Á×Ëá¸Æ·¨ Á×Ëá¸ÆDNA¸´ºÏÎïÎü¸½Ï¸°ûĤ±»Ï¸°ûÄÚÍÌ Îȶ¨×ªÈ¾

˲ʱÐÔתȾ ²»ÊÊÓÃÓÚÔ­´úϸ°û

²Ù×÷¼ò±ãµ«Öظ´ÐÔ²î

ÓÐЩϸ°û²»ÊÊÓÃ

µç´©¿×·¨

¸ßÂö³åµçÑ¹ÆÆ»µÏ¸°ûĤµç룬DNAͨ¹ýĤÉÏÐγɵÄС¿×µ¼Èë Îȶ¨×ªÈ¾

˲ʱÐÔתȾ

ËùÓÐϸ°û ÊÊÓÃÐԹ㵫ϸ°ûÖÂËÀÂʸߣ¬DNAºÍϸ°ûÓÃÁ¿´ó£¬ Ðè¸ù¾Ý²»Í¬Ï¸°ûÀàÐÍÓÅ»¯µç´©¿×ʵÑéÌõ¼þ

ÑôÀë×ÓÐÔµÄÖ¬ÖÊÌå·¨ ´øÕýµçµÄÖ¬ÖÊÌåÓëºËËá´ø¸ºµçµÄÁ×Ëá»ùÍÅÐγɸ´ºÏÎﱻϸ°ûÄÚÍÌ Îȶ¨×ªÈ¾

˲ʱÐÔתȾ

ËùÓÐϸ°û ÊÊÓÃÐԹ㣬תȾЧÂʸߣ¬

ÖØ¸´ÐԺõ«×ªÈ¾Ê±Ðè³ýѪÇå

תȾЧ¹ûËæÏ¸°ûÀàÐͱ仯´ó

²¡¶¾½éµ¼·¨ Äæ×ªÂ¼²¡¶¾ ͨ¹ýÇÖȾËÞÖ÷ϸ°û½«ÍâÔ´»ùÒòÕûºÏµ½È¾É«ÌåÖÐ Îȶ¨×ªÈ¾

ÌØ¶¨ËÞÖ÷ϸ°û ¿ÉÓÃÓÚÄÑתȾµÄϸ°û¡¢Ô­´úϸ°û£¬ÌåÄÚϸ°ûµÈ

µ«Ð¯´ø»ùÒò²»ÄÜÌ«´ó

ϸ°ûÐè´¦·ÖÁÑÆÚ

Ð迼Âǰ²È«ÒòËØ

ÏÙ²¡¶¾ ˲ʱתȾ

ÌØ¶¨ËÞÖ÷ϸ°û ¿ÉÓÃÓÚÄÑתȾµÄϸ°û

Ð迼Âǰ²È«ÒòËØ

Biolistic ¿ÅÁ£´«µÝ·¨ ½«DNAÓÃÏÔÎ¢ÖØ½ðÊô¿ÅÁ£³Áµí£¬ÔÙ½«°ü±»ºÃµÄ¿ÅÁ£Óõ¯µÀ×°ÖÃͶÉäÈëϸ°û£¬DNAÔÚ°ûÄÚÖð²½ÊÍ·Å£¬±í´ï ˲ʱÐÔתȾ ¿ÉÓÃÓÚ£ºÈËµÄ±íÆ¤Ï¸°û£¬ÏËάԭϸ°û£¬ÁܰÍϸ°ûϵÒÔ¼°Ô­´úϸ°û

ÏÔ΢עÉä·¨

ÓÃÏÔ΢²Ù×÷½«DNAÖ±½Ó×¢Èë°Ðϸ°ûºË Îȶ¨×ªÈ¾

˲ʱÐÔתȾ תȾϸ°ûÊýÓÐÏÞ

¶àÓÃÓÚ¹¤³Ì¸ÄÔì»òת»ùÒò¶¯ÎïµÄÅß̥ϸ°û

Plasmid Purification Methods vs.Transfection Efficiency

ͼ1. Primary rabbit gastric parietal cells were transfected with a GFP reporter plasmid prepared using the methods indicated. Transfections were performed using Effectene Reagent or a commonly used liposome reagent (Liposome C). The bars represent the percentage of total cells expressing GFP as determined by scoring the number of green fluorescent cells 48 h post-transfection. Data represent the average of 6¨C9 replicate dishes using more than 2 different DNA preparations for each purification method. Data kindly provided by J. Parente and C. Chew, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, USA.



Plasmid Purity and Quantity vs.Transfection Efficiency





ͼ2.Effect of the amount and quality of DNA (a luciferase reporter plasmid) on transfection efficiency in CHO SSF variants grown in suspension under serum-free conditions. Each point represents the mean of three independent experiments; bars represent standard deviations; Rel. LU: relative light units. Data kindly provided by M. O. Zang-Gandor, Novartis AG, Basel, Switzerland.



¡¡







³ýÉÏÊö´«Í³·½·¨Í⣬µÂ¹úQIAGEN¹«Ë¾½üÄêÍÆ³öÁ˼¸ÖÖ¸ïеļ¼Êõ£¬ÒÔÆäÊÊÓÃËÞÖ÷·¶Î§¹ã£¬²Ù×÷¼ò±ã£¬¶Ôϸ°û¶¾ÐÔС£¬×ªÈ¾Ð§ÂʸßÊܵ½Ñо¿ÕßÃǵÄÇàíù¡£¾ßÌ嵨·ÖÒÔϼ¸ÖÖ£º



1. »îÐÔdendrimers£ºSuperfect Transfection Reagent

Dendrimers ÊÇÒ»¸ö¸ß¶È·ÖÖ¦µÄÇòÐηÖ×Ó£¬·ÖÖ¦´ÓÇòÐÄ·ÅÉä×´·¢³ö£¬ÖÕÖ¹ÓÚ´øµçºÉµÄ°±»ù¼¯ÍÅ¡£ÓÉÓÚËüÊÇ»¯Ñ§ºÏ³ÉµÄ£¬Óо«È·µÄ´óСºÍÐÎ×´£¬±£Ö¤Ò»ÖµÄתȾ¸´ºÏÎïÐγɺÍתȾµÄÖØ¸´ÐÔ¡£²¿·ÖµØ»îÐÔ¸ÄÔìʹËü¾ßÓиü¸ßµÄµ¯ÐÔ£¨¼ûͼ1£©Í¬Ñù£¬ÓÃËüתȾʱҲ²»ÓóýѪÇ壬¶Ôϸ°û¶¾ÐÔС£¬×ªÈ¾Ð§Âʸߡ£



Schematic diagram of an activated and non-activated dendrimer. A portion of the activated dendrimer molecule is enlarged to show the chemical structure of the molecular branches.

ͼ3 Dendrimers½á¹¹Ê¾Òâͼ





¡¡



2. רÃÅΪ³£ÓÃϸ°ûÓÅ»¯µÄ¨DPolyfect Transfection Reagent



QIAGEN»¹×¨ÃÅΪʵÑéÊÒ³£ÓÃϸ°û£ºCOS-7£¬NIH/3T3£¬HeLa£¬293£¬CHOÓÅ»¯Éè¼ÆÁË»ùÓÚ»îÐÔdendrimers¼¼ÊõµÄPolyfect transfection reagent£¬²Ù×÷¸ü¼Ó¼ò±ã£¬¶øÇÒ¼Û¸ñ¾­¼Ã¡£



¡¡



3. ¸ÄÁ¼µÄÖ¬ÀàתȾÊÔ¼Á¨DEffectene transfection reagent

³ýÁËÔÚÖ¬ÀàµÄ½á¹¹ÉÏÓÐËù¸Ä½øÍ⣬Ëü»¹ÔöÌíÁËÔöÇ¿·Ö×Ó£¨Enhancer molecular£©½«DNAŨËõºóÓëתȾÊÔ¼Á·´Ó¦£¨¼ûͼ2£©£¬²»½öתȾЧÂʸߣ¬»¹´ó´ó½ÚÊ¡ÁËDNAÓÃÁ¿£¨Ö»ÐèÒ»°ãÖ¬ÖÊÌåµÄ1/5£©¡£´ËÍ⣬ÓëÒ»°ãÖ¬ÖÊÌåÏà±È£¬ËüÔÚתȾʱÎÞÐè³ýѪÇ壬¼È¼ò»¯Á˲Ù×÷£¬¸üÌá¸ßÁ˶ÔѪÇåÃô¸ÐµÄÔ­´úϸ°ûµÈµÄתȾЧÂÊ¡££¨¼ûͼ£³£áºÍ£â²Ù×÷Á÷³Ì±È½Ï£©¡£



ͼ3.A Liposome-Mediated Transfection





¡¡

ͼ3.B Effectene procedure





¡¡



4. ×îÐÂתRNAµÄ¨DTransmessenger transfection reagent

RNAתȾ²»ÒÀÀµÆô¶¯×Ó£¬ÎÞÐèת¼ֱ½Ó±í´ï¹¦Äܵ°°×£¬ÊDz»Í¬ÓÚDNAתȾµÄÁíÒ»ÖÖ˼·£¬ÓÈÆä¶ÔÖÊÁ£DNAתȾÀ§ÄѵÄÇé¿öϸüÊÇÒ»¸öºÃ·½·¨¡£´ËÍâRNAתȾ»¹¿ÉÒÔÓÃ×÷RNA²¡¶¾£¬RNA·­ÒëÑо¿¼°RNA¸ÉÈÅ£¨RNAi£©ÊµÑé¡£»ùÓÚ¸ÄÁ¼Ö¬À༼ÊõµÄתȾÊÔ¼ÁTransmessenger transfection reagentÊÇ×îÐÂÍÆ³öµÄרÃÅÊÊÓÃÓÚת¸÷ÖÖRNAµÄתȾÊÔ¼Á£¬ÅäÓÐŨËõRNAµÄÔöÇ¿·Ö×Ó£¬ÎÞRNAøÎÛȾ£¬²Ù×÷·½±ã£¬×ªÈ¾Ð§Âʸߡ££¨¼ûÁ÷³Ìͼͼ£´¼°×ªÈ¾Ð§¹ûͼͼ£µ£©





¡¡



´ËÍ⣬QIAGENÍøwww.QIAGEN.com/transfectiontoolsÌṩËüµÄËùÓÐתȾÊÔ¼ÁµÄÊÊÓÃϸ°ûÖê¼°·¢±íÎÄÏ×µÄÔÚÏß²éѯ£¬ÒÔ±ã¹ã´óÓû§¸ü¿ì¸üÓÐЧµØÑ¡ÔñºÏÊʵÄתȾÊÔ¼Á¼°Éè¼Æ×ªÈ¾ÊµÑé¡£ÎÒÃǽ«¼ÌÐø×·×ÙÕâ·½ÃæµÄм¼Êõ¼°Ó¦Óþ¡¿ìÌṩ¸ø´ó¼Ò¡£







ͼ5 Western blots of transfected HeLa-S3 cell extracts using lamin A/C- or vimentin-specific monoclonal antibodies. Cells were transfected using the indicated reagents. TM: TransMessenger Transfection Reagent; siRNA; short interfering RNA; ODN: scrambled 24mer oligodeoxynucleotide.

A Lamin A/C expression was significantly reduced in cells that had been transfected with TransMessenger Reagent-siRNA complexes.

B Expression was not suppressed in cells that were untransfected, transfected using TransMessenger Reagent or siRNA alone, or transfected with a scrambled ODN¨CTransMessenger Reagent complex.[/watermark]

[ Last edited by zhoukoulk on 2008-11-24 at 14:49 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÇÞÊÒÂ¥µÄ´óÒ¯¡¢´óÂè¶¼ÊÇÕÜѧ¼Ò£¬ËûÃÇÿÌì¶¼ÔÚ˼¿¼ÈËÀà×î¸ù±¾µÄÈý¸öÎÊÌ⣺ÄãÊÇË­£¿Äã´ÓÄĶùÀ´£¿ÒªÈ¥ÄĶù£¿
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wwangfeng

Òø³æ (ÕýʽдÊÖ)

³Ïʵ×öÈË̤ʵ×öÊÂ

¼Ó·Ö,×îºÃÂ¥Ö÷Äܸø³öÁ´½Ó,ÏÂÔØ±È½Ï·½±ã,¶øÇÒͼƬҲ±È½ÏÆëÈ«.
×öÈËÒªÖª×ã,×öÊÂÒª²»Öª×ã,×öѧÎÊÒªÖª²»×ã
2Â¥2004-02-13 20:04:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rb

ľ³æ (ÖøÃûдÊÖ)

С±¿³æ³æ

ºÜ±§Ç¸ÁË£¬ÊÇÒÔǰ×Ô¼ºÏÂÔØµÄ¶«Î÷£¬µ±Ê±¾ÍûÓÐͼƬ£¬ÁíÍâÒ²ÏëÉÏ´«Ò»Ð©×Ô¼ºµÄÐĵ㬲»¹ý²»»áÌù¸½¼þ£¬Çë½ÌÁË£º£©
ÇÞÊÒÂ¥µÄ´óÒ¯¡¢´óÂè¶¼ÊÇÕÜѧ¼Ò£¬ËûÃÇÿÌì¶¼ÔÚ˼¿¼ÈËÀà×î¸ù±¾µÄÈý¸öÎÊÌ⣺ÄãÊÇË­£¿Äã´ÓÄĶùÀ´£¿ÒªÈ¥ÄĶù£¿
3Â¥2004-02-13 21:05:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

someso

ľ³æ (ÕýʽдÊÖ)

´ó¸ç
4Â¥2004-02-13 21:35:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rb

ľ³æ (ÖøÃûдÊÖ)

С±¿³æ³æ

¶àлsomeso
ÀÏÐÖ
ÇÞÊÒÂ¥µÄ´óÒ¯¡¢´óÂè¶¼ÊÇÕÜѧ¼Ò£¬ËûÃÇÿÌì¶¼ÔÚ˼¿¼ÈËÀà×î¸ù±¾µÄÈý¸öÎÊÌ⣺ÄãÊÇË­£¿Äã´ÓÄĶùÀ´£¿ÒªÈ¥ÄĶù£¿
5Â¥2004-02-13 22:36:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

h66769

Òø³æ (ÕýʽдÊÖ)

0.5

thanks
Su27°¿ÏèС²©Ê¿
6Â¥2004-02-13 23:33:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
±¾Ìû½öÂ¥Ö÷¿É¼û
7Â¥2004-03-02 23:33:10
ÒÑÔÄ   ÉêÇëKEPI   »Ø¸´´ËÂ¥   ±à¼­   ²é¿´ÎÒµÄÖ÷Ò³

1

8Â¥2004-03-05 15:28:57
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ rb µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á +5 1ËïÎò¿Õ 2026-03-17 6/300 2026-03-19 23:46 by zcl123
[¿¼ÑÐ] 0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑо­Àú ÓжþÇøÎÄÕ +18 rare12345 2026-03-18 18/900 2026-03-19 22:36 by ѧԱ8dgXkO
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤ Çóµ÷¼Á +14 enenenhui 2026-03-13 15/750 2026-03-19 21:53 by allen-yin
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +4 z1z2z3879 2026-03-14 6/300 2026-03-19 17:18 by fei626-918
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷°²½»Í¨´óѧ²ÄÁϹ¤³Ìרҵ 282·ÖÇóµ÷¼Á +5 ·ãÇÅZL 2026-03-18 7/350 2026-03-19 14:52 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338 +5 ²Ì´óÃÀÅ® 2026-03-13 5/250 2026-03-19 10:44 by ÊÇСÁõѽ¡«
[¿¼ÑÐ] 26µ÷¼Á/²ÄÁÏ/Ó¢Ò»Êý¶þ/×Ü·Ö289/ÒѹýAÇøÏß +7 ²½´¨¿á×Ï123 2026-03-13 7/350 2026-03-18 17:12 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 311Çóµ÷¼Á +6 26ÑÐ0 2026-03-15 6/300 2026-03-18 14:43 by haxia
[¿¼ÑÐ] »·¾³¹¤³Ìµ÷¼Á +8 ´ó¿Édigkids 2026-03-16 8/400 2026-03-18 09:36 by zhukairuo
[¿¼ÑÐ] ¿¼ÑÐÇóµ÷¼Á +3 éÙËÌ. 2026-03-17 4/200 2026-03-17 21:43 by ÓÐÖ»ÀêÅ«
[¿¼ÑÐ] 326Çóµ÷¼Á +5 Éϰ¶µÄСÆÏ 2026-03-15 6/300 2026-03-17 17:26 by ruiyingmiao
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +4 ÕÅvvvv 2026-03-15 6/300 2026-03-17 17:15 by ruiyingmiao
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á +5 heming3743 2026-03-16 5/250 2026-03-17 14:03 by Ó¸ÒÌ«¼àÍõ¹«¹«
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 318Çóµ÷¼Á +3 Yanyali 2026-03-15 3/150 2026-03-16 16:41 by houyaoxu
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶Çóµ÷¼Á +6 Ì«Ïë½ø²½ÁË0608 2026-03-16 6/300 2026-03-16 16:13 by kykm678
[¿¼ÑÐ] ÖпÆÔº²ÄÁÏ273Çóµ÷¼Á +4 yzydy 2026-03-15 4/200 2026-03-16 15:59 by Gaodh_82
[¿¼ÑÐ] 070305Çóµ÷¼Á +3 mlpqaz03 2026-03-14 4/200 2026-03-15 11:04 by peike
[¿¼ÑÐ] ±¾¿ÆÄϾ©´óѧһ־Ը´¨´óҩѧ327 +3 ÂóÌï¸ûÕß 2026-03-14 3/150 2026-03-14 20:04 by ÍâÐÇÎÄÃ÷
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-03-13 4/200 2026-03-14 08:37 by zhukairuo
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û